Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members
Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requi...
Gespeichert in:
Veröffentlicht in: | British journal of dermatology (1951) 2007-11, Vol.157 (5), p.1030-1031 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1031 |
---|---|
container_issue | 5 |
container_start_page | 1030 |
container_title | British journal of dermatology (1951) |
container_volume | 157 |
creator | Berroeta, L. Man, I. Goudie, D.R. Whatley, S.D. Elder, G.H. Ibbotson, S.H. |
description | Summary
Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype. |
doi_str_mv | 10.1111/j.1365-2133.2007.08117.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68382866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21058872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</originalsourceid><addsrcrecordid>eNqNkUtv3CAUhVHVKpk8_kLFpt3ZvYDBuFIXbR5No5GySdYI4-uGkR9T8Kjxvw_OjJplw4bH-e7l6hxCKIOcpfVlkzOhZMaZEDkHKHPQjJX50zuy-ie8JytIUgaVEsfkJMYNABMg4Ygcs7JkTHK5Iu3aTki3ASMOk538ONCxpRjm6TGM29Hj5F2SxyldwvZxDt5-pc5GpAHTy0Tt0NDfOLxwdrDdHH1cWrS2991Me-xrDPGMfGhtF_H8sJ-Sh-ur-4ubbH3389fF93XmiqooM42K11wXyHTRFuBaIXWJWEnGwEFdoVO1FNyVqqhr2whwNXDZNIXmSjthxSn5vO-bRv6zwziZ3keHXWcHHHfRKC0010r9F-QMpNYlT6Degy6MMQZszTb43obZMDBLGGZjFs_N4rlZwjAvYZinVPrx8Meu7rF5LTy4n4BPB8BGZ7s22MH5-MpVrNICIHHf9txf3-H85gHMj9vL5SSeAXH0pks</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21058872</pqid></control><display><type>article</type><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</creator><creatorcontrib>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</creatorcontrib><description>Summary
Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.2007.08117.x</identifier><identifier>PMID: 17711525</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age of Onset ; Biological and medical sciences ; Dermatology ; erythropoietic protoporphyria ; Female ; ferrochelatase ; Ferrochelatase - genetics ; ferrochelatase mutations ; Genotype ; Humans ; inheritance ; Medical sciences ; Metabolic diseases ; Middle Aged ; Other metabolic disorders ; Photosensitivity Disorders - etiology ; Pigments (porphyrias, hyperbilirubinemias...) ; porphyrins ; Protoporphyria, Erythropoietic - complications ; Protoporphyria, Erythropoietic - diagnosis ; Protoporphyria, Erythropoietic - genetics ; Skin involvement in other diseases. Miscellaneous. General aspects</subject><ispartof>British journal of dermatology (1951), 2007-11, Vol.157 (5), p.1030-1031</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</citedby><cites>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.2007.08117.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.2007.08117.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19198300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17711525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berroeta, L.</creatorcontrib><creatorcontrib>Man, I.</creatorcontrib><creatorcontrib>Goudie, D.R.</creatorcontrib><creatorcontrib>Whatley, S.D.</creatorcontrib><creatorcontrib>Elder, G.H.</creatorcontrib><creatorcontrib>Ibbotson, S.H.</creatorcontrib><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary
Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</description><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>erythropoietic protoporphyria</subject><subject>Female</subject><subject>ferrochelatase</subject><subject>Ferrochelatase - genetics</subject><subject>ferrochelatase mutations</subject><subject>Genotype</subject><subject>Humans</subject><subject>inheritance</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Other metabolic disorders</subject><subject>Photosensitivity Disorders - etiology</subject><subject>Pigments (porphyrias, hyperbilirubinemias...)</subject><subject>porphyrins</subject><subject>Protoporphyria, Erythropoietic - complications</subject><subject>Protoporphyria, Erythropoietic - diagnosis</subject><subject>Protoporphyria, Erythropoietic - genetics</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv3CAUhVHVKpk8_kLFpt3ZvYDBuFIXbR5No5GySdYI4-uGkR9T8Kjxvw_OjJplw4bH-e7l6hxCKIOcpfVlkzOhZMaZEDkHKHPQjJX50zuy-ie8JytIUgaVEsfkJMYNABMg4Ygcs7JkTHK5Iu3aTki3ASMOk538ONCxpRjm6TGM29Hj5F2SxyldwvZxDt5-pc5GpAHTy0Tt0NDfOLxwdrDdHH1cWrS2991Me-xrDPGMfGhtF_H8sJ-Sh-ur-4ubbH3389fF93XmiqooM42K11wXyHTRFuBaIXWJWEnGwEFdoVO1FNyVqqhr2whwNXDZNIXmSjthxSn5vO-bRv6zwziZ3keHXWcHHHfRKC0010r9F-QMpNYlT6Degy6MMQZszTb43obZMDBLGGZjFs_N4rlZwjAvYZinVPrx8Meu7rF5LTy4n4BPB8BGZ7s22MH5-MpVrNICIHHf9txf3-H85gHMj9vL5SSeAXH0pks</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Berroeta, L.</creator><creator>Man, I.</creator><creator>Goudie, D.R.</creator><creator>Whatley, S.D.</creator><creator>Elder, G.H.</creator><creator>Ibbotson, S.H.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200711</creationdate><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><author>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>erythropoietic protoporphyria</topic><topic>Female</topic><topic>ferrochelatase</topic><topic>Ferrochelatase - genetics</topic><topic>ferrochelatase mutations</topic><topic>Genotype</topic><topic>Humans</topic><topic>inheritance</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Other metabolic disorders</topic><topic>Photosensitivity Disorders - etiology</topic><topic>Pigments (porphyrias, hyperbilirubinemias...)</topic><topic>porphyrins</topic><topic>Protoporphyria, Erythropoietic - complications</topic><topic>Protoporphyria, Erythropoietic - diagnosis</topic><topic>Protoporphyria, Erythropoietic - genetics</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berroeta, L.</creatorcontrib><creatorcontrib>Man, I.</creatorcontrib><creatorcontrib>Goudie, D.R.</creatorcontrib><creatorcontrib>Whatley, S.D.</creatorcontrib><creatorcontrib>Elder, G.H.</creatorcontrib><creatorcontrib>Ibbotson, S.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berroeta, L.</au><au>Man, I.</au><au>Goudie, D.R.</au><au>Whatley, S.D.</au><au>Elder, G.H.</au><au>Ibbotson, S.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2007-11</date><risdate>2007</risdate><volume>157</volume><issue>5</issue><spage>1030</spage><epage>1031</epage><pages>1030-1031</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary
Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17711525</pmid><doi>10.1111/j.1365-2133.2007.08117.x</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0963 |
ispartof | British journal of dermatology (1951), 2007-11, Vol.157 (5), p.1030-1031 |
issn | 0007-0963 1365-2133 |
language | eng |
recordid | cdi_proquest_miscellaneous_68382866 |
source | MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current) |
subjects | Age of Onset Biological and medical sciences Dermatology erythropoietic protoporphyria Female ferrochelatase Ferrochelatase - genetics ferrochelatase mutations Genotype Humans inheritance Medical sciences Metabolic diseases Middle Aged Other metabolic disorders Photosensitivity Disorders - etiology Pigments (porphyrias, hyperbilirubinemias...) porphyrins Protoporphyria, Erythropoietic - complications Protoporphyria, Erythropoietic - diagnosis Protoporphyria, Erythropoietic - genetics Skin involvement in other diseases. Miscellaneous. General aspects |
title | Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T02%3A01%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20presentation%20of%20erythropoietic%20protoporphyria:%20case%20report%20and%20genetic%20analysis%20of%20family%20members&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Berroeta,%20L.&rft.date=2007-11&rft.volume=157&rft.issue=5&rft.spage=1030&rft.epage=1031&rft.pages=1030-1031&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1111/j.1365-2133.2007.08117.x&rft_dat=%3Cproquest_cross%3E21058872%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21058872&rft_id=info:pmid/17711525&rfr_iscdi=true |